Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium-Reference-Cited by-同舟云学术

Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Published:2017-02 Issue:2 Volume:71 Page:204-209
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Wells J. Connor,Stukalin Igor,Norton Craig,Srinivas Sandy,Lee Jae Lyun,Donskov Frede,Bjarnason Georg A.,Yamamoto Haru,Beuselinck Benoit,Rini Brian I.,Knox Jennifer J.,Agarwal Neeraj,Ernst D. Scott,Pal Sumanta K.,Wood Lori A.,Bamias Aristotelis,Alva Ajjai S.,Kanesvaran Ravindran,Choueiri Toni K.,Heng Daniel Y.C.

Publisher

Elsevier BV

Subject

Urology

Reference21 articles.

1. Treatment selection in metastatic renal cell carcinoma: expert consensus;Escudier;Nat Rev Clin Oncol,2012

2. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;New Engl J Med,2015

3. Cabozantinib versus everolimus in advanced renal-cell carcinoma;Choueiri;New Engl J Med,2015

4. Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy;Calvo;Eur J Cancer,2014

5. First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC;Ko;Br J Cancer,2014

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series;BMC Cancer;2024-07-05

2. Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis;Journal of Urologic Oncology;2024-03-31

3. Prognostic Models in Metastatic Renal Cell Carcinoma;Hematology/Oncology Clinics of North America;2023-10

4. Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers;Diagnostics;2023-07-20

5. Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma;Frontiers in Oncology;2023-02-16